PCI Biotech Holding ASA (OSL:PCIB)
0.1600
-0.0065 (-3.90%)
Apr 1, 2026, 1:05 PM CET
PCI Biotech Holding ASA Market Cap
PCI Biotech Holding ASA has a market cap or net worth of 5.97 million as of April 2, 2026. Its market cap has decreased by -87.36% in one year.
Market Cap
5.97M
Enterprise Value
-7.36M
Revenue
4.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since June 23, 2008, PCI Biotech Holding ASA's market cap has decreased from 97.50M to 5.97M, a decrease of -93.87%. That is a compound annual growth rate of -14.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 5.97M | -34.96% |
| Dec 30, 2025 | 9.18M | -79.29% |
| Dec 30, 2024 | 44.34M | -43.29% |
| Dec 29, 2023 | 78.20M | 2.20% |
| Dec 30, 2022 | 76.52M | -85.26% |
| Dec 30, 2021 | 519.21M | -50.14% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.32B |
| Thor Medical ASA | 1.77B |
| Nykode Therapeutics AS | 1.12B |
| ArcticZymes Technologies ASA | 1.00B |
| Lytix Biopharma AS | 799.76M |
| Zelluna ASA | 493.35M |
| SoftOx Solutions AS | 275.20M |
| Oncoinvent ASA | 209.23M |